Development and validation of a radiomics nomogram for predicting outcomes following combined radiotherapy and modern chemotherapy in early-stage extranodal nasal-type NK/T-cell lymphoma: a multicenter study.
Imaging analysis combined with clinical data predicts treatment outcomes in aggressive Asian lymphomas, supporting personalized therapy choices.
This multicenter study developed and validated a radiomics nomogram for predicting outcomes in early-stage extranodal nasal-type NK/T-cell lymphoma (ENKTL), one of the most common aggressive lymphomas in Asia with distinct biology and treatment sensitivity. The nomogram integrates quantitative imaging biomarkers with clinical features to support individualized treatment planning in a disease where stratifying risk for combined modality therapy remains challenging.
What the study was
- Study design
- multicenter_retrospective_cohort
- Population
- Early-stage extranodal nasal-type NK/T-cell lymphoma patients
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- Ann Hematol
Why it surfaced
Multicenter validation of a radiomics prognostic tool for NK/T-cell lymphoma—a rare aggressive lymphoma with high unmet need for outcome prediction; extranodal ENKTL has unique radiotherapy sensitivity making imaging-based prognosis clinically actionable; published in Annals of Hematology.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.